Straumann (OTCMKTS:SAUHY) Sees Strong Trading Volume – Still a Buy?

Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) saw unusually-strong trading volume on Thursday. Approximately 879,660 shares traded hands during mid-day trading, an increase of 624% from the average daily volume of 121,576 shares. The stock last traded at $11.70 and had previously closed at $11.72.

Analysts Set New Price Targets

Several research analysts have commented on SAUHY shares. BMO Capital Markets started coverage on shares of Straumann in a research note on Wednesday, July 8th. They set an “outperform” rating on the stock. Citigroup reaffirmed a “sell” rating on shares of Straumann in a research report on Wednesday, October 21st. Deutsche Bank Aktiengesellschaft downgraded Straumann from a “buy” rating to a “hold” rating in a research note on Friday, August 21st. Berenberg Bank upgraded shares of Straumann to a “strong-buy” rating in a research report on Thursday, September 17th. Finally, UBS Group upgraded Straumann from a “neutral” rating to a “buy” rating in a report on Tuesday, September 1st. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, one has given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Straumann has a consensus rating of “Moderate Buy”.

Check Out Our Latest Analysis on Straumann

Straumann Stock Up 0.6%

The business has a fifty day moving average of $11.42 and a two-hundred day moving average of $11.66.

Straumann Company Profile

(Get Free Report)

Straumann Group is a Switzerland-based dental technology company headquartered in Basel. Founded in 1954, the company develops, manufactures and distributes products used in tooth replacement, restorative dentistry and oral tissue regeneration. Its offerings are designed for dental professionals, laboratories and patients across a range of clinical applications.

The company’s portfolio includes dental implants, implant-supported prosthetics, biomaterials for bone and tissue regeneration, orthodontic aligners and digital dentistry solutions.

Featured Stories

Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.